SPOTLIGHT: Chinese pharma recalls counterfeit drug

After discovering a syndicate counterfeiting its products, Chinese drug maker Holley-Cotec Pharmaceuticals is recalling anti-malarials supplied to Kenya. Twenty thousand doses of Duo-cotecxin, a type of artemisinin drug recommended by the World Health Organization for use against malaria, are involved in the recall. The company analyzed the fake meds and found they had very low levels of active ingredients. Kenyan officials said this is the first case of a counterfeit artemisinin drug, but fake anti-malarials are becoming a worldwide problem and could spur drug resistance in the germ. Holley-Cotec says it intends to use new tamper-proof technology on the replacement doses it supplies. Report

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.